HomeComparePKBOW vs PLD

PKBOW vs PLD: Dividend Comparison 2026

PKBOW yields 20202.02% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKBOW wins by $57988137149625106432.00M in total portfolio value
10 years
PKBOW
PKBOW
● Live price
20202.02%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57988137149625106432.00M
Annual income
$57,428,928,743,751,610,000,000,000.00
Full PKBOW calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — PKBOW vs PLD

📍 PKBOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKBOWPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKBOW + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKBOW pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKBOW
Annual income on $10K today (after 15% tax)
$1,717,171.72/yr
After 10yr DRIP, annual income (after tax)
$48,814,589,432,188,870,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PKBOW beats the other by $48,814,589,432,188,870,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKBOW + PLD for your $10,000?

PKBOW: 50%PLD: 50%
100% PLD50/50100% PKBOW
Portfolio after 10yr
$28994068574812553216.00M
Annual income
$28,714,464,371,875,805,000,000,000.00/yr
Blended yield
99.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

PKBOW
No analyst data
Altman Z
-52.0
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKBOW buys
0
PLD buys
0
No recent congressional trades found for PKBOW or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKBOWPLD
Forward yield20202.02%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$57988137149625106432.00M$5.91M
Annual income after 10y$57,428,928,743,751,610,000,000,000.00$4,750,725.19
Total dividends collected$57951242634511319040.00M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PKBOW vs PLD ($10,000, DRIP)

YearPKBOW PortfolioPKBOW Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$2,030,902$2,020,202.02$11,241$540.96+$2.02MPKBOW
2$385,615,342$383,442,277.01$13,019$991.13+$385.60MPKBOW
3$68,455,310,249$68,042,701,832.74$15,801$1,870.97+$68455.29MPKBOW
4$11,362,120,801,776$11,288,873,619,809.51$20,609$3,701.21+$11362120.78MPKBOW
5$1,763,290,309,334,738$1,751,132,840,076,837.00$29,919$7,867.97+$1763290309.30MPKBOW
6$255,866,846,080,109,380$253,980,125,449,121,180.00$50,631$18,617.74+$255866846080.06MPKBOW
7$34,717,188,276,404,167,000$34,443,410,751,098,450,000.00$105,528$51,352.20+$34717188276404.06MPKBOW
8$4,404,848,409,251,598,600,000$4,367,701,017,795,846,700,000.00$287,364$174,449.42+$4404848409251598.00MPKBOW
9$522,624,678,386,435,660,000,000$517,911,490,588,536,450,000,000.00$1,081,760$774,280.77+$522624678386435648.00MPKBOW
10$57,988,137,149,625,104,000,000,000$57,428,928,743,751,610,000,000,000.00$5,908,209$4,750,725.19+$57988137149625106432.00MPKBOW

PKBOW vs PLD: Complete Analysis 2026

PKBOWStock

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

Full PKBOW Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this PKBOW vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKBOW vs SCHDPKBOW vs JEPIPKBOW vs OPKBOW vs KOPKBOW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.